Stay updated on Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial

Sign up to get notified when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:21:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-05-29T06:09:21.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-05-14T23:35:36.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T14:23:16.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-23T13:52:36.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about the study objectives and bridging therapy for KTE-X19 in adult participants with relapsed/refractory B-precursor acute lymphoblastic leukemia. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    17%
    Check dated 2025-04-16T10:52:21.000Z thumbnail image

Stay in the know with updates to Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.